[HTML][HTML] Clinical Outcomes of Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations
…, S Bisland-Naggan, O Barnett-Griness… - … England Journal of …, 2007 - Mass Medical Soc
Background Some features of breast cancer in women with a BRCA1 mutation suggest that
hereditary breast cancer has a poor outcome. We conducted a national population-based …
hereditary breast cancer has a poor outcome. We conducted a national population-based …
[PDF][PDF] Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
…, G Rennert, F Lejbkowicz, O Barnett-Griness… - The American Journal of …, 2008 - cell.com
Germline mutations in BRCA1 and BRCA2 confer high risks of breast cancer. However,
evidence suggests that these risks are modified by other genetic or environmental factors that …
evidence suggests that these risks are modified by other genetic or environmental factors that …
Maternal complications associated with multiple cesarean deliveries
V Nisenblat, S Barak, OB Griness, S Degani… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: The claim that a planned repeat cesarean delivery is safer than a trial of labor
after cesarean may not be applicable to women who desire larger families. The aim of this …
after cesarean may not be applicable to women who desire larger families. The aim of this …
Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study
W Saliba, N Gronich, O Barnett-Griness… - The American journal of …, 2016 - Elsevier
Background CHADS 2 and CHA 2 DS 2 -VASc are validated scores used to predict stroke in
patients with atrial fibrillation. Many of the individual risk factors included in these scores are …
patients with atrial fibrillation. Many of the individual risk factors included in these scores are …
Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients
K Shulman, I Cohen, O Barnett‐Griness, A Kuten… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Metastatic colorectal cancer is frequently treated with irinotecan, a
topoisomerase‐I inhibitor. The UGT1A1 gene encodes for an enzyme that metabolizes irinotecan, …
topoisomerase‐I inhibitor. The UGT1A1 gene encodes for an enzyme that metabolizes irinotecan, …
Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants
O Barnett-Griness, N Stein, A Kotler, W Saliba… - Heart, 2022 - heart.bmj.com
Objective Clinical models such as the HAS-BLED (standing for Hypertension, Abnormal liver/renal
function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly, Drug/…
function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly, Drug/…
MutYH mutation carriers have increased breast cancer risk
…, I Cohen, M Pinchev, HS Rennert, O Barnett‐Griness - Cancer, 2012 - Wiley Online Library
BACKGROUND: Variants of the mutY homolog gene MutYH, a DNA repair gene, are
associated with increased risk of colorectal cancer; however, it remains unclear whether these …
associated with increased risk of colorectal cancer; however, it remains unclear whether these …
Association between vaccination with the BNT162b2 mRNA coronavirus disease 2019 vaccine and noninfectious uveitis: a population-based study
O Tomkins-Netzer, S Sar, O Barnett-Griness… - Ophthalmology, 2022 - Elsevier
… Author links open overlay panel Oren Tomkins-Netzer MD, PhD 1 2 , Shaul Sar MD 1 , Ofra
Barnett-Griness PhD 3 , Binyamin Friedman MD 1 , Hana Shyriaieva MD 1 4 , Walid Saliba …
Barnett-Griness PhD 3 , Binyamin Friedman MD 1 , Hana Shyriaieva MD 1 4 , Walid Saliba …
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single‐Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A …
O Barnett‐Griness, G Rennert… - Clinical …, 2023 - Wiley Online Library
Among patients treated with irinotecan, homozygous carriers of the UGT1A1*28 allele are at
increased risk for neutropenia, but UGT1A1 genotype alone does not account for irinotecan‐…
increased risk for neutropenia, but UGT1A1 genotype alone does not account for irinotecan‐…
Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score–matched analysis
W Saliba, JE Schliamser, I Lavi, O Barnett-Griness… - Heart Rhythm, 2017 - Elsevier
Background Catheter ablation reduces recurrence of atrial fibrillation and improves quality
of life. Only few studies have assessed the effect of catheter ablation on long-term outcomes. …
of life. Only few studies have assessed the effect of catheter ablation on long-term outcomes. …